Submit Paper
  • Home
  • Benefits of Biosimilars in Inflammatory Bowel Disease, Issues, and Future Directions
International Journal of Gastroenterology and Hepatology

International Journal of Gastroenterology and Hepatology

Benefits of Biosimilars in Inflammatory Bowel Disease, Issues, and Future Directions
Brian Feagan

Onuigbo, Department of Pathology, Medical Foundation and Clinic, Enugu, Nigeria.

Correspondence to Author: Brian Feagan
Abstract:

Citation:

Brian Feagan. Benefits of Biosimilars in Inflammatory Bowel Disease, Issues, and Future Directions. International Journal of Gastroenterology and Hepatology 2022.

IJOGH

International Journal of Gastroenterology and Hepatology (ISSN 2834-0884) is the branch of medicine dealing with the digestive system and disorders. Physicians practicing in this field are called Gastroenterologists.

Useful Links

Contact Info

  • Website: . International Journal of Gastroenterology and Hepatology
  • Location: 6355 N Clairmont Avenue Suite 201 CHICAGO, IL 60659
  • Email: contact@ijgah.com

Follow Us

Copyright © 2022 IJOGH